Patents by Inventor Reinhard J. Warnking

Reinhard J. Warnking has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240123262
    Abstract: Apparatus and methods for deactivating bronchial nerves extending along a bronchial branch of a mammalian subject to treat asthma and related conditions. An ultrasonic transducer (11) is inserted into the bronchus as, for example, by advancing the distal end of a catheter (10) bearing the transducer into the bronchial section to be treated. The ultrasonic transducer emits focused ultrasound so as to heat tissues throughout circular impact volume (13) as, for example, at least about 1 cm3 encompassing the bronchus to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual bronchial nerves.
    Type: Application
    Filed: December 20, 2023
    Publication date: April 18, 2024
    Applicant: AerWave Medical, Inc.
    Inventors: Reinhard J. Warnking, Satoshi Nishiaoki
  • Publication number: 20240123263
    Abstract: Apparatus and methods for deactivating bronchial nerves extending along a bronchial branch of a mammalian subject to treat asthma and related conditions. An ultrasonic transducer (11) is inserted into the bronchus as, for example, by advancing the distal end of a catheter (10) bearing the transducer into the bronchial section to be treated. The ultrasonic transducer emits focused ultrasound so as to heat tissues throughout circular impact volume (13) as, for example, at least about 1 cm3 encompassing the bronchus to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual bronchial nerves.
    Type: Application
    Filed: December 20, 2023
    Publication date: April 18, 2024
    Applicant: AerWave Medical, Inc.
    Inventors: Reinhard J. Warnking, Satoshi Nishiaoki
  • Publication number: 20230135085
    Abstract: Apparatus and methods for deactivating bronchial nerves extending along a bronchial branch of a mammalian subject to treat asthma and related conditions. An ultrasonic transducer (11) is inserted into the bronchus as, for example, by advancing the distal end of a catheter (10) bearing the transducer into the bronchial section to be treated. The ultrasonic transducer emits focused ultrasound so as to heat tissues throughout circular impact volume (13) as, for example, at least about 1 cm3 encompassing the bronchus to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual bronchial nerves.
    Type: Application
    Filed: January 29, 2021
    Publication date: May 4, 2023
    Inventors: Reinhard J. Warnking, Satoshi Nishiaoki
  • Patent number: 11607568
    Abstract: Apparatus and methods for deactivating bronchial nerves extending along the secondary bronchial branches of a mammalian subject to treat asthma and related conditions. An ultrasonic transducer (11) is inserted into the bronchus as, for example, by advancing the distal end of a catheter (10) bearing the transducer into the secondary bronchial section to be treated. The ultrasonic transducer emits circumferential ultrasound so as to heat tissues throughout circular impact volume (13) as, for example, at least about 1 cm3 encompassing the bronchus to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual bronchial nerves. The apparatus and methods utilized for lung tumor ablation.
    Type: Grant
    Filed: June 17, 2021
    Date of Patent: March 21, 2023
    Assignee: AERWAVE MEDICAL, INC.
    Inventors: Reinhard J. Warnking, Satoshi Nishiaoki
  • Publication number: 20230057488
    Abstract: Apparatus and methods for deactivating bronchial nerves extending along the secondary bronchial branches of a mammalian subject to treat asthma and related conditions. An ultrasonic transducer (11) is inserted into the bronchus as, for example, by advancing the distal end of a catheter (10) bearing the transducer into the secondary bronchial section to be treated. The ultrasonic transducer emits circumferential ultrasound so as to heat tissues throughout circular impact volume (13) as, for example, at least about 1 cm3 encompassing the bronchus to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual bronchial nerves. The apparatus and methods utilized for lung tumor ablation.
    Type: Application
    Filed: September 28, 2022
    Publication date: February 23, 2023
    Inventors: Reinhard J. Warnking, Satoshi Nishiaoki
  • Patent number: 11565135
    Abstract: Apparatus and methods for deactivating bronchial nerves extending along the secondary bronchial branches of a mammalian subject to treat asthma and related conditions. An ultrasonic transducer (11) is inserted into the bronchus as, for example, by advancing the distal end of a catheter (10) bearing the transducer into the secondary bronchial section to be treated. The ultrasonic transducer emits circumferential ultrasound so as to heat tissues throughout circular impact volume (13) as, for example, at least about 1 cm3 encompassing the bronchus to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual bronchial nerves. The apparatus and methods utilized for lung tumor ablation.
    Type: Grant
    Filed: August 2, 2021
    Date of Patent: January 31, 2023
    Assignee: AERWAVE MEDICAL, INC.
    Inventors: Reinhard J. Warnking, Satoshi Nishiaoki
  • Publication number: 20220126062
    Abstract: Apparatus and methods for deactivating renal nerves extending along a renal artery of a mammalian subject to treat hypertension and related conditions. An ultrasonic transducer (30) is inserted into the renal artery (10) as, for example, by advancing the distal end of a catheter (18) bearing the transducer into the renal artery. The ultrasonic transducer emits unfocused ultrasound so as to heat tissues throughout a relatively large impact volume (11) as, for example, at least about 0.5 cm3 encompassing the renal artery to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual renal nerves.
    Type: Application
    Filed: October 19, 2021
    Publication date: April 28, 2022
    Applicant: ReCor Medical, Inc.
    Inventor: Reinhard J. WARNKING
  • Patent number: 11278313
    Abstract: An apparatus and methods for transeptal punctures provide audible feedback to an operator or clinician with information to identify an intended needle or instrument pathway. Despite improved safety and simplification of the TSP itself, the apparatus enables the operator to optimize a crossing angle for various procedures, including PV isolation, valve repair, and appendage closure.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: March 22, 2022
    Assignee: AERWAVE MEDICAL, INC.
    Inventor: Reinhard J. Warnking
  • Patent number: 11273330
    Abstract: Apparatus and methods for deactivating pulmonary nerves extending along the main bronchi of a mammalian subject to reduce ARDS effects by advancing an ultrasound transducer into the right and subsequently left main bronchus. The ultrasound transducer emits circumferential ultrasound so as to heat a circumferential tissue volume encompassing the right and left main bronchus. The energy of <10 W acoustic for <5 sec will not be sufficient to cause tissue necrosis but sufficient to inactivate nerve conduction. This treatment can be performed without locating or focusing on individual pulmonary nerves.
    Type: Grant
    Filed: April 28, 2021
    Date of Patent: March 15, 2022
    Assignee: AerWave Medical, Inc.
    Inventor: Reinhard J. Warnking
  • Publication number: 20220008753
    Abstract: Apparatus and methods for deactivating bronchial nerves extending along the secondary bronchial branches of a mammalian subject to treat asthma and related conditions. An ultrasonic transducer (11) is inserted into the bronchus as, for example, by advancing the distal end of a catheter (10) bearing the transducer into the secondary bronchial section to be treated. The ultrasonic transducer emits circumferential ultrasound so as to heat tissues throughout circular impact volume (13) as, for example, at least about 1 cm3 encompassing the bronchus to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual bronchial nerves. The apparatus and methods utilized for lung tumor ablation.
    Type: Application
    Filed: August 2, 2021
    Publication date: January 13, 2022
    Inventors: Reinhard J. Warnking, Satoshi Nishiaoki
  • Publication number: 20210402218
    Abstract: Apparatus and methods for deactivating pulmonary nerves extending along the main bronchi of a mammalian subject to reduce ARDS effects by advancing an ultrasound transducer into the right and subsequently left main bronchus. The ultrasound transducer emits circumferential ultrasound so as to heat a circumferential tissue volume encompassing the right and left main bronchus. The energy of <10 W acoustic for <5 sec will not be sufficient to cause tissue necrosis but sufficient to inactivate nerve conduction. This treatment can be performed without locating or focusing on individual pulmonary nerves.
    Type: Application
    Filed: April 28, 2021
    Publication date: December 30, 2021
    Inventor: Reinhard J. Warnking
  • Patent number: 11185662
    Abstract: Apparatus and methods for deactivating renal nerves extending along a renal artery of a mammalian subject to treat hypertension and related conditions. An ultrasonic transducer (30) is inserted into the renal artery (10) as, for example, by advancing the distal end of a catheter (18) bearing the transducer into the renal artery. The ultrasonic transducer emits unfocused ultrasound so as to heat tissues throughout a relatively large impact volume (11) as, for example, at least about 0.5 cm3 encompassing the renal artery to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual renal nerves.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: November 30, 2021
    Assignee: ReCor Medical, Inc.
    Inventor: Reinhard J. Warnking
  • Publication number: 20210316161
    Abstract: Apparatus and methods for deactivating bronchial nerves extending along the secondary bronchial branches of a mammalian subject to treat asthma and related conditions. An ultrasonic transducer (11) is inserted into the bronchus as, for example, by advancing the distal end of a catheter (10) bearing the transducer into the secondary bronchial section to be treated. The ultrasonic transducer emits circumferential ultrasound so as to heat tissues throughout circular impact volume (13) as, for example, at least about 1 cm3 encompassing the bronchus to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual bronchial nerves. The apparatus and methods utilized for lung tumor ablation.
    Type: Application
    Filed: June 17, 2021
    Publication date: October 14, 2021
    Inventors: Reinhard J. Warnking, Satoshi Nishiaoki
  • Publication number: 20210267627
    Abstract: An apparatus and methods for transeptal punctures provide audible feedback to an operator or clinician with information to identify an intended needle or instrument pathway. Despite improved safety and simplification of the TSP itself, the apparatus enables the operator to optimize a crossing angle for various procedures, including PV isolation, valve repair, and appendage closure.
    Type: Application
    Filed: February 19, 2021
    Publication date: September 2, 2021
    Inventor: Reinhard J. Warnking
  • Patent number: 11020618
    Abstract: Apparatus and methods for deactivating pulmonary nerves extending along the main bronchi of a mammalian subject to reduce ARDS effects by advancing an ultrasound transducer into the right and subsequently left main bronchus. The ultrasound transducer emits circumferential ultrasound so as to heat a circumferential tissue volume encompassing the right and left main bronchus. The energy of <10 W acoustic for <5 sec will not be sufficient to cause tissue necrosis but sufficient to inactivate nerve conduction. This treatment can be performed without locating or focusing on individual pulmonary nerves.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: June 1, 2021
    Assignee: AerWave Medical, Inc.
    Inventor: Reinhard J. Warnking
  • Publication number: 20200170702
    Abstract: Ablation device including a probe structure 10 having a proximal end 12 and a distal end 14. Probe structure 10 includes a tubular first catheter 16, a tubular second catheter 18 surrounding the first catheter and a tubular guide catheter extending within the first catheter 16. The first catheter 16 carries a cylindrical ultrasonic transducer 20 adjacent its distal end. The transducer 20 is connected to a source of electrical excitation. The ultrasonic waves emitted by the transducer 20 are directed at the heart wall tissue. Once the tissue reaches the target temperature, the electrical excitation is turned on and off to maintain the tissue at the largest temperature. Alternatively, the transducer 20 is subjected to continuous excitation at one power level and upon the tissue reaching the target temperature, the power level of the continuous excitation is switched to a second lower power level.
    Type: Application
    Filed: December 2, 2019
    Publication date: June 4, 2020
    Applicant: ReCor Medical, Inc.
    Inventor: Reinhard J. WARNKING
  • Publication number: 20180361117
    Abstract: Apparatus and methods for deactivating renal nerves extending along a renal artery of a mammalian subject to treat hypertension and related conditions. An ultrasonic transducer (30) is inserted into the renal artery (10) as, for example, by advancing the distal end of a catheter (18) bearing the transducer into the renal artery. The ultrasonic transducer emits unfocused ultrasound so as to heat tissues throughout a relatively large impact volume (11) as, for example, at least about 0.5 cm3 encompassing the renal artery to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual renal nerves.
    Type: Application
    Filed: August 3, 2018
    Publication date: December 20, 2018
    Applicant: ReCor Medical, Inc.
    Inventor: Reinhard J. WARNKING
  • Patent number: 9981108
    Abstract: Apparatus and methods for deactivating renal nerves extending along a renal artery of a mammalian subject to treat hypertension and related conditions. An ultrasonic transducer (30) is inserted into the renal artery (10) as, for example, by advancing the distal end of a catheter (18) bearing the transducer into the renal artery. The ultrasonic transducer emits unfocused ultrasound so as to heat tissues throughout a relatively large impact volume (11) as, for example, at least about 0.5 cm3 encompassing the renal artery to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual renal nerves.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: May 29, 2018
    Assignee: ReCor Medical, Inc.
    Inventor: Reinhard J. Warnking
  • Patent number: 9943666
    Abstract: Apparatus and methods for deactivating renal nerves extending along a renal artery of a mammalian subject to treat hypertension and related conditions. An ultrasonic transducer (30) is inserted into the renal artery (10) as, for example, by advancing the distal end of a catheter (18) bearing the transducer into the renal artery. The ultrasonic transducer emits unfocused ultrasound so as to heat tissues throughout a relatively large impact volume (11) as, for example, at least about 0.5 cm3 encompassing the renal artery to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual renal nerves.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: April 17, 2018
    Assignee: ReCor Medical, Inc.
    Inventor: Reinhard J. Warnking
  • Publication number: 20170027453
    Abstract: A guide wire has a distal end incorporating a coil and a capacitive element that form a resonance circuit with a resonance frequency that is responsive to the pressure of blood external to the guide wire. The resonance frequency can be detected wirelessly, or through two contacts at the proximal wire end, or through one brush contact located inside an insertion sheath and a ground electrode. Wireless detection can be implemented via a second resonance circuit, and electronics for determining the frequency when the first and second circuits are in resonance with each other.
    Type: Application
    Filed: September 21, 2016
    Publication date: February 2, 2017
    Inventors: Reinhard J. WARNKING, Matthew J. POLLMAN